Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 832

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 832
---
 General Shareholders Meeting on January 30, 2025. Upon the closing of the transaction and subject to the cash balances of NLS and the Company, upon that date, the current shareholders of the Company will hold up to 85% of the issued and paid -upshare capital of NLS following the merger (hereinafter, the “Merged Company”), and the shares of the Merged Company will be traded on Nasdaq. The closing of the merger transaction is subject to fulfillment of conditions precedent. The agreement stipulates a number of conditions precedent related, among others, to actions that NLS is required to take prior to the closing of the merger transaction, including regarding the arrangement of the continued trading of its shares on Nasdaq and its compliance with the threshold conditions required for this, which are expected to be examined by Nasdaq as part of the submission of the application for trading of the Merged Company close to the date of closing. (See Note 23C.) J.On August 29, 2024, Dr. Kfir Molakandov was appointed as the Company’s VP of Research and Development. Note 18: — EQUITY A. Composition of the share capital

|                                                                    |     |      December 31 |     |            |     |             |     |            |   |
|                                                                    |     |             2024 |     |            |     |        2023 |     |            |   |
|                                                                    |     |       Authorized |     | Issued and 
    paid up |     |  Authorized |     | Issued and 
    paid up |   |
|                                                                    |     | Number of shares |     |            |     |             |     |            |   |
| Ordinary shares, p.v. NIS 0.1 per share (p.v. USD $0.03 per share) |     |      150,000,000 |     |  4,193,689 |     | 150,000,000 |     |  4,193,689 | * |

____________ *Adjusted retrospectively due to a reverse share split. See Notes 18I and 18K.

Annex G-33

KADIMASTEM LTD.
NOTES TO FINANCIAL STATEMENTS Note 18: — EQUITY (cont.) B. Movement in share capital Issued and paid -upcapital:

|                                 |     |   Number of 
      shares |   |     | USD par value